TriptolideAlternative Names: PG 490
Latest Information Update: 24 Jan 2013
At a glance
- Originator Abbott Laboratories; Fujian Institute of Medical Science; Harold C. Simmons Arthritis Research Center; National Cancer Center (Tokyo); Pharmagenesis; Stanford University; University of Texas Southwestern Medical Center
- Class Antineoplastics; Diterpenes; Epoxy compounds; Phenanthrenes
- Mechanism of Action Immunomodulators; Immunosuppressants
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
Highest Development Phases
- Discontinued Breast cancer; Gastric cancer; Inflammation; Rheumatoid arthritis; Solid tumours; Transplant rejection